Drug Therapy in Hydatid Disease of the Liver
Medical management of hydatidosis has been tried with many drugs including antimony, arsenic, iodides and mercury (Arif et al. 2008). However there was no evidence of any success. Lately the benzimidazole carbamate group of drugs was introduced and was found effective against larval stage of both E. granulosus and E. multilocularis. This benzimidazole carbamate group of drugs blocks the uptake of glucose in the parasite, thereby causing depletion of its glycogen stores (Arif et al. 2008). The drug causes death of germinal membrane cells, and the cyst loses its ability to maintain haemostasis and integrity (Heath et al. 1975).
- El-Mufti M. Surgical management of hydatid disease. London: Butterworths; 1989.Google Scholar
- Evangelos C, et al. Perioperative benzimidazole therapy in human hydatid liver disease. Int Surg. 1995;80:131–3.Google Scholar
- Milicevic MN. Hydatid disease. In: Blumgart LH, Fong Y, editors. Surgery of liver and biliary tract. 3rd ed. London: W.B. Saunders; 2000.Google Scholar
- Sherlock S. Hydatid disease: disease of liver and biliary system. Oxford: Blackwell Scientific; 1981. p. 247–452.Google Scholar